The ECV day-1 outcome for Atrial Fibrillation data collection: a retrospective analysis of outcomes on day-1 after electrical cardioversion

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON27758

Enrollment

500

Registered

2021-04-15

Start date

2021-04-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrium fibrillation

Interventions

None, observational

Eligibility

Inclusion criteria

Inclusion criteria: - Patients who underwent ECV in Amsterdam UMC, location AMC in 2019 and 2020 - Patients > 18 years

Exclusion criteria

Exclusion criteria: - Patients who completed an objection to the re-use of care data.

Design outcomes

Primary

Measure	Time frame
The number of patients with complications related to the anaesthesia or the ECV procedure between 0-2 and 2-24 hours after the procedure.	—

Secondary

Measure	Time frame
The occurrence of stroke/ complications up to 30 days after the ECV procedure. The type, severity, treatment, and outcomes of the reported complications.	—

Contacts

Public ContactFemke Piersma

Amsterdam Universiteits Medisch Centrum. locatie AMC

f.r.piersma@amsterdamumc.nl020 566 3794

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)